Non-alcoholic Fatty Liver Disease and the Gut Microbiota: Exploring the Connection

Journal Title: Gastro - Open Journal - Year 2015, Vol 1, Issue 2

Abstract

As the gut microbiota continues to be implicated in an increasing number of disease processes, a plethora of new literature surrounding its complexity and role in the maintenance of intestinal homeostasis has become available. Non-alcoholic fatty liver disease (NAFLD) has become the most common nonviral liver disease worldwide and a number of predisposing risk factors for NAFLD have been identified, including obesity and insulin resistance. Recent evidence supports a role for the gut microbiota in the pathogenesis of these risk factors and NAFLD, itself. Additionally, changes in the gut microbiota can lead to activation of immune responses that have the potential to promote progression of NAFLD to the more severe Nonalcoholic steatohepatitis (NASH). Furthermore, the gut microbiota may serve as a potential target for therapeutic options to treat NAFLD. This review seeks to explain the role of the gut microbiota in the pathogenesis of NAFLD and its risk factors, while also discussing potential future treatment options directed at correcting imbalances with in the gut microbiota.

Authors and Affiliations

David A. Johnson

Keywords

Related Articles

Effect of Chronic Proton Pump Inhibitor Use on Serum Magnesium Levels in Pediatric Patients

Hypomagnesemia has been reported in adult patients on Proton Pump Inhibitor (PPI) therapy. No studies have described the effect of this class on medications on Magnesium (Mg) levels in children. This was a retrospective...

Microgenderome: An Important Variable for Developing Therapeutic Strategies?

A close association of microbiota in human health continues to emerge. Microbiota has been implicated in autoimmune disorders such as type I diabetes mellitus, inflammatory bowel disease, rheumatoid arthritis and multipl...

Coalescent Cyclical Vomiting: A Manifestation of Narcotic Bowel Syndrome?

This illustrative case suggests mechanisms that may contribute to disease progression and complications in adults with Cyclical Vomiting Syndrome (CVS). Symptoms initially followed a characteristic pattern in the context...

Percutaneous Endoscopic Gastrostomy: Use and Abuse in Clinical Practice

Nowadays, Percutaneous Endoscopic Gastrostomy (PEG) is considered the method of choice for long-term enteral feeding, and is spreading all over the world because of its effectiveness and easy carrying out. This review en...

Endoscopy: From Diagnosis to Therapeutics

Two decades ago, gastroenterologists used endoscopy for the diagnosis of Gastrointestinal (GI) lesions, thereby helping surgeons to localize lesion that necessitated resection and treatment with surgery. Today, the gastr...

Download PDF file
  • EP ID EP555907
  • DOI 10.17140/GOJ-1-107
  • Views 96
  • Downloads 0

How To Cite

David A. Johnson (2015). Non-alcoholic Fatty Liver Disease and the Gut Microbiota: Exploring the Connection. Gastro - Open Journal, 1(2), 30-43. https://europub.co.uk/articles/-A-555907